A glucosylceramide synthase inhibitor prevents the cytotoxic effects of Shiga toxin-2 on human renal tubular epithelial cells

Abstract

Shiga toxin-2 binds to the globotriaosyl-ceramide receptor on the plasma membrane of target cells. The highlevel expression of this receptor in renal epithelial cells may account, at least in part, for acute renal failure observed inchildren with hemolytic uremic syndrome. The cytotoxic effect of Shiga toxin-2 was assayed on primary cultures of humanrenal tubular epithelial cells treated with a new specific inhibitor of glucosylceramide synthase (C-9), the ratelimitingfirst step in the glycosphingolipid biosynthetic pathway. The treatment of the cells with 1-5 M C-9 for at least24 h significantly neutralized the action of 1 ng/ml Shiga toxin-2 on cell viability. The expression levels of globotriaosylceramidesignificantly decreased when cells were incubated with 1 M C-9 for 48 h. We propose here that prevention ofglobotriaosyl-ceramide synthesis by the C-9 could be a novel substrate inhibition therapy to neutralize Shiga toxin-2 actionin renal epithelial cells.